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Toxoplasma gondii is a parasite of birds and mammals.
Cats are the only definitive host and thus the only source
of infective oocysts, but other mammals and birds can
develop tissue cysts. Although feline infections are typi-
cally asymptomatic, infection during human pregnancy
can cause severe disease in the fetus. Cat owners can
reduce their pets’ exposure risk by keeping all cats
indoors and not feeding them raw meat. Humans usually
become infected through ingestion of oocyst-contami-
nated soil and water, tissue cysts in undercooked meat,
or congenitally. Because of their fastidious nature, the
passing of non-infective oocysts, and the short duration
of oocyst shedding, direct contact with cats is not
thought to be a primary risk for human infection.
Toxoplasmosis in cats and other animals
Toxoplasma gondii is a widespread zoonotic protozoan that
infects most, if not all, species of birds and mammals. As
the definitive hosts for this organism, felines are the only
animals that pass oocysts in their feces (Table 1; Box 1),
although intermediate hosts can harbor infective tissue
cysts. Most feline infections occur post-natally through
ingestion of infected tissue cysts or rarely oocysts, although
congenital infections can occur [1]. Feline infections are
typically subclinical; congenitally infected kittens are the
most likely to have clinical signs of infection, but previously
clinically healthy adult cats may can also be affected [1,4].
Common symptoms of T. gondii infection in cats can
include fever, ocular inflammation, anorexia, lethargy,
abdominal discomfort and neurologic abnormalities [4].
Cats are more likely to shed oocysts following ingestion
of tissue cysts rather than tachyzoites or oocysts [5]. The
ingestion of one bradyzoite will lead to feline infection,
whereas a feline must ingest 1000 oocysts to develop an
infection [5]. Following the ingestion of tissue cysts con-
taining bradyzoites, some bradyzoites convert to tachy-
zoites and some to T. gondii schizonts, which replicate
asexually in the intestinal tissue before beginning sexual
reproduction (Figure 1) [5]. Although most cats only shed
oocysts once in their lives, following infection, experimen-
tal infection and immunosuppression resulted in repeated
shedding by kittens 20–21 days following the immunosup-
pressive event [6]. In addition, oocyst shedding was
induced in a non-immunosuppressed kitten following a
second inoculation with infected mouse brain homogenate
[6]. It is thought that infection to one genotype of T. gondii
confers immunity to all genotypes, but this phenomenon
has not been explored in cats. In a mouse model, immunity
was more effective using homologous rather than heter-
ologous strains of the parasite [7,8].
Toxoplasma gondii infection can cause severe neuro-
logic or ocular disease in the fetus during human preg-
nancy. Humans acquire their infections from ingestion of
oocyst-contaminated soil and water, from tissue cysts in
undercooked meat, by transplantation, blood transfusion,
laboratory accidents, or congenitally [1] (Figure 1). Most
people infected after birth are asymptomatic; however,
some may develop fever, malaise, and lymphadenopathy.
Congenital toxoplasmosis often results in debilitating ocu-
lar disease, causing (among other manifestations) retino-
choroitis and anterior uveitis [9]. Historically, women
demonstrating exposure to T. gondii prior to pregnancy
through serology were considered safe from future infec-
tion and risk to the fetus. However, apparent recrudescent
infections during pregnancy can occur in immunocompe-
tent mother although few cases have been reported [10]. A
case of maternal T. gondii infection and subsequent fetal
infection was reported in a 31-year old French woman with
serological evidence of previous T. gondii exposure. The
strain isolated from this pregnancy is likely to be the same
strain as in the original infection [10], suggesting that
exposure prior to pregnancy does not automatically confer
protection from future infections that occur following
recrudescence of T. gondii [10]. Post-natally infected
humans, especially those with immunosuppression, can
develop ocular complications such as retinochoroiditis.
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Toxoplasmic encephalitis, pulmonitis, or other systemic
disease can be seen in patients with immunosuppressive
disorders and those undergoing immunosuppressive
therapy for circumstances such as organ transplantation.
Prevalence and risk factors for feline and human
infection
The estimated seroprevalance for T. gondii in domestic cats
(Felis catus), worldwide, is 30–40% [2]. There has been no
national estimate ofT. gondii prevalence in cats in theUSA;
however, local seroprevalences have varied from 16% to
80% [3]. Serologic testing of clinically ill cats with toxoplas-
mosis as a differential diagnosis resulted in an overall
seroprevalence of 31.6% [4]. Regional prevalences varied
in conformance with different climates; prevalence in the
drier southwest (NewMexico, Utah and Arizona) was lower
(16.1%), whereas prevalence in humid climates was much
higher (59.2% in Hawaii). These studies demonstrate that
cats in the USA are commonly exposed to T. gondii. How-
ever, because of their fastidious nature, the fact that oocysts
are not infective when passed, and the short duration of
oocyst shedding, direct contact with cats is not thought to be
a risk for human infection [1,4]. Cat owners can reduce their
pets’ exposure risk by: (i) keeping all cats indoors so they do
not become infected by ingesting rodents and birds; (ii) not
feeding cats raw meat; and (iii) controlling potential inter-
mediate hosts such as rodents [10]. In cat populations in
North Carolina, Nutter et al. [11] reported a higher sero-
prevalence for T. gondii in feral cats than in pet cats, and
higher seroprevalence inpet cats thathadaccess to outdoors
than those that did not, thus supporting the case for restrict-
ing outdoor access for pet cats.
Toxoplasma gondii is found in humans, worldwide,
under a variety of climates and socio-economic circum-
stances. In the USA, the seroprevalence of T. gondii
appears to be declining. A seroprevalence of 14.1% was
reported during 1988–1994 in persons 12–49 years of age,
whereas a seroprevalence of 9.0% was reported during
1999–2004 in this same age group (the prevalence values
for these two time periods were age-adjusted and standar-
dized to the US population for the comparison) [12]. A
primary risk factor for human toxoplasmosis is contact
with infective oocysts (Figure 1), which are found in cat
feces (>1 day after shed), contaminated soil, and water
[13]. Thus, gardening and playing in sandboxes increases
Table 1. Wild felids as definitive host for Toxoplasma gondiia.
Definitive host Oocyst shedding Refs
Expermental Natural
African wild cat (Felis lybica) Yes
b No [32]
Amur leopard cat (Felis euptilurus) No Yes
b [33]
Asian leopard (Felis bengalensis) Yes No [34]
Yesb No [35]
Bobcat (Lynx rufus) No Yes
b [36]
Yesb No [35]
Cheetah (Acinonyx jubatus) No Yes
b [36]
Yesb No [32]
Cougar (Felis concolor) No Yes
b [36]
Yesb No [35]
Cougar (Felis concolor vancouverensis) No Yes
b [37]
Geoffroy’s cat (Oncifelis geoffroyi) No Yes
c [38]
No Yesb [33]
Iriomote cat (Felis iriomotensis) No Yes
b [39]
Jaguarundi (Felis yagouaroundi) Yes
b No [40]
Lion (Panthera leo) No Yes
d [41]
Yesb No [32]
Mountain lion (Felis concolar) No Yes
b [36]
Ocelot (Felis pardalis ) Yes
b No [40]
No Yes [42]
Pallas cat (Felis manul) No Yes
b [43]
No Yesd [44]
Yesb No [32]
Pampas cat (Oncifelis colocolo) No Yes
c [38]
Siberian tiger (Panthera tigris altaica) No Yes
b [45]
Wild cat (Felis silvestris) No Yes
b [33]
aData from Ref. [5].
bConfirmed by bioassay in mice.
cConfirmed by bioassay in pigs.
dImmunohistochemical post-mortem examination.
Figure 1. Transmission of Toxoplasma gondii. Members of the cat family (Felidae)
are the only known definitive hosts for the sexual stages of Toxoplasma gondii,
and thus are the main reservoirs of infection. Cats become infected with T. gondii
by carnivorism . After tissue cysts or oocysts are ingested by the cat, viable
organisms are released and invade epithelial cells of the small intestine, where
they undergo an asexual followed by a sexual cycle and then form oocysts, which
are excreted. The unsporulated oocyst takes one to five days after excretion to
sporulate (become infective). Although cats shed oocysts for only one to two
weeks, large numbers may be shed. Oocysts can survive in the environment for
several months and are remarkably resistant to disinfectants, freezing, and drying,
but are killed by heating to 70 8C for 10 minutes. Human infection may be acquired
in several ways: A) ingestion of undercooked infected meat containing
Toxoplasma cysts ; B) ingestion of the oocyst from fecally contaminated hands
or food ; C) organ transplantation or blood transfusion; D) transplacental
transmission; E) accidental inoculation of tachyzoites. The parasites form tissue
cysts, most commonly in skeletal muscle, myocardium, and brain; these cysts may
remain throughout the life of the host. This figure is an adaptation of the
Toxoplasma gondii life cycle generated by the Centers for Disease Control and
Prevention, http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm.
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the risk for humans of exposure to sporulated oocysts.
Ways to minimize exposure risk include wearing gloves
while gardening or otherwise interactingwith soil, wearing
gloves when disposing of cat litter, and washing hands
after these activities [14]. Ingesting undercookedmeat also
provides an important avenue for T. gondii infection
through the ingestion of viable tissue cysts. Undercooked
pork is another common risk factor for T. gondii exposure;
beef is not believed to be a major player, however, raw
ground beef was found to be a risk factor in a US epi-
demiological study [13]. Other risk factors for infection
include not washing kitchen knives after they have been
used to cut raw meat, fruits, and vegetables, as well as
infrequent hand washing [15].
Environmental contamination by T. gondii oocysts is a
concern from both public health and biodiversity
perspectives. Surface run-off containing feline feces con-
taining T. gondii oocysts enters aquatic ecosystems, such
as the marine habitat on the California coast [16]. An
unusual genotype (Type X) of T. gondii has been ident-
ified to cause mortality in sea otters; infection with this
genotype has also been found in several other coastal
dwelling species, including marine bivalves and other
filter-feeding invertebrates [16,17]. Sea otters (Enhydra
lutris nereis) in these contaminated habitats might ingest
invertebrates that concentrate T. gondii oocysts as a
consequence of their feeding habits and as a result,
prevalence in sea otters is high [16]. Sea otters that died
of clinical toxoplasmosis had CNS abnormalities, beha-
vioral changes, and reproductive problems such as abor-
tion or neonatal death [16].
Diagnosis and treatment of infection in cats
Options for ante-mortem diagnosis in cats include fecal
examination for oocysts (Figure 2) and serologic testing;
definitive diagnosis of toxoplasmosis can be difficult to
accomplish [18]. Most infected cats will shed oocysts only
at a single point in their lifetime, generally for a period of
one to two weeks, and it has been estimated that only1%
of cats at any given time are actively shedding (Table 2) [1];
this estimate was supported through the observation of T.
gondii-like oocysts in a population of Californian cats [19],
although tests to confirm the oocyst identity were not
reported. The probability of finding oocysts in the feces
of a cat is low; a survey of cats in Germany and other
European countries recently reported detection ofT. gondii
oocysts (Figure 2) in 26 of 24,106 (0.11%) fecal samples [1].
Complicating fecal detection is the fact that oocysts of other
coccidia morphologically resemble those of T. gondii (Ham-
mondia hammondi and Besnoitia spp); molecular and
bioassay techniques are used to distinguish between
organisms, and mouse bioassay is the only definitive con-
firmationmethod (Table 2) [5]. Serology can also be used as
a diagnostic tool; however, positive results must be prop-
erly interpreted. Although a single positive IgG titer
indicates exposure, clinical toxoplasmosis is indicated by
a positive IgM titer or a fourfold increase in IgG levels in
paired serum samples taken 2–4 weeks apart [4,18].
Because most cats seroconvert after they have finished
shedding oocysts, the use of serology in pet cats as an
indication of exposure risk to humans is limited [1,4].
There is no approved treatment for clinical toxoplasmo-
sis in cats. Sulphonamides, trimethoprim, pyrimethamine,
and clindamycin, either alone or in combination, have been
used to treat cats with clinical toxoplasmosis, with varying
results [20]. Ponazuril, an approved treatment for equine
protozoalmyeloencephalitis caused bySarcocystis neurona
in horses, is excellent in treating acute toxoplasmosis in
mice [20] and in preventing recrudescent encephalitis
Box 1. Cats, clonality of Toxoplasma gondii and disease
Cats and wild felids are essential to the persistence of T. gondii in
hosts such as grazing animals (e.g. sheep and deer) because they
serve as the sole source of the infectious oocysts that contaminate
the environment. At the same time, it is only in the feline host that
sexual multiplication of this parasite takes place, so cats serve as the
only site wherein genetic recombination and re-assortment of this
parasite can occur. For the past several decades, it has been
considered that, in spite of sexual recombination, there is only
minimal genetic diversity among different isolates of T. gondii from
around the world, with isolates being placed mainly in one of three
genetic strains, Type I, II, and III [28]. However, it has recently been
shown that there is significantly more genetic diversity in isolates
from Brazil [29]. In one recent study, viable T. gondii isolates
recovered from tissues of five to seven naturally infected cats from
St Kitts, West Indies, had mixed infections with different genotypes
[30]. The work indicated that the environment there was already
contaminated with T. gondii oocysts shed by seropositive cats,
suggesting that, in St Kitts at least, there is perhaps a high
percentage of mixed infections in feral cats. No information yet
exists to explain the drivers for this genetic diversity on St Kitts;
additionally, no information exists to describe variability on other
islands of the archipelago. We are only beginning to unravel the
actual genetic relationship between virulence and the genetic
makeup of the different strains of T. gondii present in the
environment and in cases of human and animal disease [28]. Work
on the genetics of virulence has indicated that some rhoptry
proteins (held in the rhoptry organelles and released at the time of
host cell penetration), for example ROP18, are linked to virulence in
different genetic strains irrespective of their genetic strain assort-
ment. Thus, work is moving towards a better understanding as to
how to recognize the potential pathogenicity of isolates, which is
important in a parasite that appears to vary in pathogenicity in
different cases. It is also apparent that we are getting closer to being
able to identify the specific sources of T. gondii responsible for
outbreaks and individual cases of T. gondii infection [31].
Figure 2. Sporulated oocyst of Toxoplasma gondii in sugar flotation of cat feces
(dimensions 12  12.5 mm. Average size of T. gondii oocyst is 10–12 mm [27]. Photo
courtesy of A. Lucio-Forster, Cornell University, USA.
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in mice [21], and should be evaluated in domestic cats. The
recommended treatment in cases of human cerebral
toxoplasmosis is pyrimethamine and sulfadiazine (plus
folinic acid) [1].
Prevention of infection in cats and humans
In the absence of an effective vaccine in humans, preven-
tion of zoonotic transmission might be the best way to
approach the problem of toxoplasmosis, and must be done
by limiting exposure to oocysts or tissue cysts. Recommen-
dations for accomplishing this include practicing good
hygiene (e.g. hand washing after soil contact, washing
fruits and vegetables that are eaten raw), freezing meat
at 12 8C for 24 hours [13] and/or cooking meat until an
internal temperature of 66 8C is reached, and not drinking
untreated water [1]. It is also recommended to keep cats
indoors, feed them commercially prepared diets, and clean
their litter boxes daily, because it takes at least one day for
the organisms to sporulate and become infectious after
being shed [4]. Recommendations specifically for pregnant
women include wearing gloves when gardening or being in
contact with soil or sand, followed by thorough hand-wash-
ing [22]. In addition, pregnant women should avoid chan-
ging cat litter if possible. Owners should also be advised to
keep dogs away from the litter box to prevent ingestion of
oocysts [23]. Health education for women of childbearing
age should include information about meat-, soil-, and cat
feces-related toxoplasmosis prevention. Immunosup-
pressed persons, including those with HIV infection,
should also be educated about how to prevent infection
[24]. Veterinarians should educate their canine-owning
clients of the importance in vaccinating against distemper,
as most cases of toxoplasmosis in dogs are seen in those not
vaccinated against this immunosuppressive virus [1].
Table 2. Prevalence of T. gondii-like oocysts in feces of cats (principally 1988–2008)a
Country No. of cats Grams of feces tested Methods No. pos (%) Refs
Micro Bioassay PCR
Argentina 50 NS Yes Yes No 1(2.0)d [46,47]
Austria 1368 NS Yes No No 27(2) [48]
Belgium 30 NS Yes No No 0 [49]
Brazil 237 1 Yes Yes Yes 3(1.2) [50]
Colombia 18 NS Yes No No 12 (66.6) [51]
143 2-10 Yes Yes No 0 [52]
Czec Republic 390 NS Yes Yes No 0 [53]
France 322 NS Yes No No 0 [54]
Germany 264 NS Yes No No 0 [55]
70b NS Yes No No (17.1) [56]
24106 NS Yes No Yes 26(0.11) [57]
2473 NS Yes No No 22 (0.9) [58]
2472 NS Yes No No 26 (1.0) [59]
441 NS Yes No No 3 (0.7) [60]
India 9 NS Yes Yes No 1(11) [61]
Iran 50 NS Yes No No 0 [62]
100 1 Yes No No 0 [63]
Israel 122 3 Yes No Yes 11(9)
e [64]
Japan 335 NS Yes Yes No 1(0.3) [65]
Mexico 200 NS Yes Yes No 14 (7.0) [66]
Mexico 200 NS Yes No No 0 [67]
New Zealand 63 NS Yes No No 0 [68]
Nigeria 52 NS Yes No No 0 [69]
Panama 383 NS NS Yes No 2 (0.5) [70]
People’s Republic of China 26 10 Yes Yes No 0 [71]
Singapore 722 1-2 Yes No No 0 [72]
Spain 382 3 Yes No No 0 [73]
592 NS Yes No No 0 [74]
Taiwan 96 NS Yes No No 0 [75]
Turkey 72 NS Yes No No 0 [76]
USA 274
c NS No Yes No 5 (1.8) [77]
206 NS Yes No No 0 [78]
450 NS Yes No No 3 (0.7) [79]
326 NS Yes No Nof 3 (0.9) [20]
263 NS Yes No No 3 (1.1) [80]
34 NS Yes yes No 0 [81]
aData from Ref. [82].
bLitters of kittens from farms.
cCats from pig farms.
dConfirmed by bioassay in mice.
eOocysts not found by microscopic examination.
fNegative by PCR.
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Vaccine development to prevent feline oocyst shedding
is ongoing, mostly involving live vaccines. There are some
disadvantages, including its limited shelf life and the risk
of infection to humans who are handling the vaccines [25].
The S48 strain Toxovax1 is a live vaccine originally
developed for use in sheep, but, when used in cats, inhibits
sexual development of T. gondii. Thus, the immune system
responds to the parasite strain, but cats are unable to
produce oocysts [25]. In sheep, this vaccine is used to
reduce tissue cyst development. The T-263 strain of T.
gondii is a livemutant strain designed to reduce or prevent
oocyst shedding by cats by developing only partially in the
feline intestinal tract [25]. Field trials with this feline
vaccine were conducted on US pig farms [25,26]. Cats were
trapped, vaccinated, and released. Following the vaccina-
tion of the resident cats on the farms, T. gondii seropre-
valence in the farmed pigs decreased, suggesting less
environmental contamination with oocysts, and thus, less
infection risk for the pigs [25,26]. There are reports of
attempted vaccination of cats using T. gondii strains modi-
fied by irradiation, chemical treatments, selected recombi-
nant antigens, and new delivery systems, including a feline
herpes-virus type 1 vehicle for delivery. All of these
vaccines supply a level of immunity to cats, but a need
exists for a killed or recombinant vaccine that could serve
as a model for human vaccination against T. gondii.
Future research
Toxoplasmosis is a potentially serious disease, but one that
is largely preventable. Informed clinicians—both in the
human and veterinary medical professions—can decrease
disease transmission while recognizing and helping to
maintain the relationships that many people have with
their domestic cats. The increased understanding of T.
gondii infection provides exciting new opportunities for
research, both in the veterinary and human medical fields
(Box 2). Because the ingestion of oocysts is an important
route of infection, future research should address the de-
velopment of new methods to detect and inactivate infec-
tive oocysts in feces, soil, and water. Studies evaluating the
survival or inactivation of the organism in commercial cat
litters would be extremely valuable. Currently there is no
information regarding cat litter and oocyst inactivation.
Large scale, national serologic and fecal surveys of indoor,
indoor/outdoor, and feral cats could also be accomplished
by obtaining blood and fecal samples from veterinary
clinics and trap/neuter/release programs. Such infor-
mation could provide insight into management strategies
to mitigate environmental contamination caused by out-
door cat populations. Finally, future projects should com-
mit to improving communication and education methods
for veterinarians, physicians, cat owners, and the general
public about toxoplasmosis risk factors and mechanisms of
prevention. Such efforts, and a means of evaluating their
impact, might promote a decline in toxoplasmosis and
transmission of T. gondii.
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